Sarcomatoid differentiation in renal cell carcinoma: Prognostic implications

International Braz J Urol

Volumn 31, Issue 1, 2005, Pages 10-16

  Dall'Oglio, Marcos F ^a,b   Lieberknecht, Marco ^a   Gouveia, Valter ^a   Sant'Anna, Alexandre C ^a   Leite, Katia R ^a   Srougi, Miguel ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Carcinoma; Kidney neoplasms; Neoplasms metastasis; Renal cell

Indexed keywords

CYTOKINE; INTERFERON; TUMOR VACCINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY SARCOMA; KIDNEY SURGERY; LIFE EXPECTANCY; MALE; METASTASIS; MICROANGIOPATHY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SAMPLING; SURVIVAL RATE; SYMPTOMATOLOGY; TUMOR DIFFERENTIATION; TUMOR NECROSIS; TUMOR VOLUME;

EID: 15844429402     PISSN: 16775538     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1677-55382005000100003     Document Type: Article

References (18)

1. Greenlee RT, Murray T, Bolden S, Wingo PA: Cancer statistics, 2000. CA Cancer J Clin. 2000; 50: 7-33.
2. Hou LT, Willis RA: Renal carcino-sarcoma, true and false. J Pathol Bacteriol. 1963; 85: 139-44.
3. Juhasz J, Sebok J, Galambos J, Kiss P: Renal carcino-sarcoma (mixed tumours) of the kidney. Int Urol Nephrol. 1980; 12: 103-8.
4. Farrow GM, Harrison EG Jr, Utz DC: Sarcomas and sarcomatoid and mixed malignant tumors of the kidney in adults. 3 Cancer. 1968; 22: 556-63.
5. Tomera KM, Farrow GM, Lieber MM: Sarcomatoid renal carcinoma. J Urol. 1983; 130: 657-9.
6. de Peralta-Venturina M, Moch H, Amin M, Tamboli P, Hailemariam S, Mihatsch M, et al.: Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol. 2001; 25: 275-84.
7. Sella A, Logothetis CJ, Ro JY, Swanson DA, Samuels ML: Sarcomatoid renal cell carcinoma. A treatable entity. Cancer. 1987; 60: 1313-8.
8. Bertoni F, Ferri C, Benati A, Bacchini P, Corrado F: Sarcomatoid carcinoma of the kidney. J Urol. 1987; 137: 25-8.
9. Ro JY, Ayala AG, Sella A, Samuels ML, Swanson DA: Sarcomatoid renal cell carcinoma: clinicopathological. A study of 42 cases. Cancer. 1987; 59: 516-26.
10. Cangiano T, Liao J, Naitoh J, Dorey F, Figlin R, Belldegrun A: Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical re-section and immunotherapy. J Clin Oncol. 1999; 17: 523-8.
11. Mian BM, Bhadkamkar N, Slaton JW, Pisters PW, Daliani D, Swanson DA, et al.: Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma. J Urol. 2002; 167: 65-70.
12. Cheville JC, Lohse CM, Zincke H, Weaver AL, Leibovich BC, Frank I, et al.: Sarcomatoid renal cell carcinoma: an examination of underlying histological subtype and an analysis of associations with patient outcome. Am J Surg Pathol. 2004; 28: 435-41.
13. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H: An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol. 2002; 168: 2395-400.
14. Selli C, Hinshaw WM, Woodard BH, Paulson DF: Stratification of risk factors in renal cell carcinoma. Cancer. 1983; 52: 899-903.
15. Pantuck AJ, Zisman A, Belldegrun AS: The changing natural history of renal cell carcinoma. J Urol. 2001; 166: 1611-23.
16. Figlin RA, Pierce WC, Kaboo R, Tso CL, Moldawer N, Gitlitz B, et al.: Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8(+) selected tumor infiltrating lymphocytes from primary tumor. J Urol. 1997; 158: 740-5.
17. Figlin RA: Renal cell carcinoma: management of advanced disease. J Urol. 1999; 161: 381-6.
18. Jocham D, Richter A, Hoffmann L, Iwig K, Fahlenkamp D, Zakrzewski G, et al.: Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial. Lancet. 2004; 363: 594-9.